Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhiping Li

Showing results (511-520 of 540) with videos related to

Pageof 54
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 2, 2018
Total neoadjuvant treatment (CAPOX plus radiotherapy) for patients with locally advanced rectal cancer with high risk factors: A phase 2 trialXin Wang, Yongyang Yu, Wenjian Meng, et al.
European Journal of Cancer (Oxford, England : 1990)|April 30, 2022
Health-related quality of life in patients with advanced well-differentiated pancreatic and extrapancreatic neuroendocrine tumors treated with surufatinib versus placebo: Results from two randomized, double-blind, phase III trials (SANET-p and SANET-ep)Jiarui Li, Yuejuan Cheng, Chunmei Bai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2019
Surufatinib in Advanced Well-Differentiated Neuroendocrine Tumors: A Multicenter, Single-Arm, Open-Label, Phase Ib/II TrialJianming Xu, Jie Li, Chunmei Bai, et al.
Clinical and Translational Science|May 7, 2010
ErbB2 induces Notch1 activity and function in breast cancer cellsJaime Lindsay, Xuanmao Jiao, Toshiyuki Sakamaki, et al.
Cancer Research|May 20, 2017
Cyclin D1 Restrains Oncogene-Induced Autophagy by Regulating the AMPK-LKB1 Signaling AxisMathew C Casimiro, Gabriele Di Sante, Agnese Di Rocco, et al.
Cancer Research|September 5, 2006
p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signalingJames Hulit, Richard J Lee, Zhiping Li, et al.
Molecular and Cellular Biology|August 15, 2003
Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivationChenguang Wang, Nagarajan Pattabiraman, Jian Nian Zhou, et al.
Cancer Research|March 15, 2015
The endogenous cell-fate factor dachshund restrains prostate epithelial cell migration via repression of cytokine secretion via a cxcl signaling moduleKe Chen, Kongming Wu, Xuanmao Jiao, et al.
The Lancet Regional Health. Western Pacific|March 5, 2024
Varenicline solution nasal spray for dry eye disease in Chinese patients: a randomized phase 3 trialLei Tian, Xiuming Jin, Jibing Wang, et al.
Oncogenesis|January 8, 2024
A cyclin D1 intrinsically disordered domain accesses modified histone motifs to govern gene transcriptionXuanmao Jiao, Gabriele Di Sante, Mathew C Casimiro, et al.
Pageof 54

Showing results (511-520 of 540) with videos related to

Sort By:
Pageof 54
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 2, 2018
Total neoadjuvant treatment (CAPOX plus radiotherapy) for patients with locally advanced rectal cancer with high risk factors: A phase 2 trialXin Wang, Yongyang Yu, Wenjian Meng, et al.
European Journal of Cancer (Oxford, England : 1990)|April 30, 2022
Health-related quality of life in patients with advanced well-differentiated pancreatic and extrapancreatic neuroendocrine tumors treated with surufatinib versus placebo: Results from two randomized, double-blind, phase III trials (SANET-p and SANET-ep)Jiarui Li, Yuejuan Cheng, Chunmei Bai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2019
Surufatinib in Advanced Well-Differentiated Neuroendocrine Tumors: A Multicenter, Single-Arm, Open-Label, Phase Ib/II TrialJianming Xu, Jie Li, Chunmei Bai, et al.
Clinical and Translational Science|May 7, 2010
ErbB2 induces Notch1 activity and function in breast cancer cellsJaime Lindsay, Xuanmao Jiao, Toshiyuki Sakamaki, et al.
Cancer Research|May 20, 2017
Cyclin D1 Restrains Oncogene-Induced Autophagy by Regulating the AMPK-LKB1 Signaling AxisMathew C Casimiro, Gabriele Di Sante, Agnese Di Rocco, et al.
Cancer Research|September 5, 2006
p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signalingJames Hulit, Richard J Lee, Zhiping Li, et al.
Molecular and Cellular Biology|August 15, 2003
Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivationChenguang Wang, Nagarajan Pattabiraman, Jian Nian Zhou, et al.
Cancer Research|March 15, 2015
The endogenous cell-fate factor dachshund restrains prostate epithelial cell migration via repression of cytokine secretion via a cxcl signaling moduleKe Chen, Kongming Wu, Xuanmao Jiao, et al.
The Lancet Regional Health. Western Pacific|March 5, 2024
Varenicline solution nasal spray for dry eye disease in Chinese patients: a randomized phase 3 trialLei Tian, Xiuming Jin, Jibing Wang, et al.
Oncogenesis|January 8, 2024
A cyclin D1 intrinsically disordered domain accesses modified histone motifs to govern gene transcriptionXuanmao Jiao, Gabriele Di Sante, Mathew C Casimiro, et al.
Pageof 54